{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:38:05Z","timestamp":1792179485705,"version":"4.4.0"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.pharmthera.2017.06.009","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T10:46:10Z","timestamp":1497955570000},"page":"99-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"special_numbering":"C","title":["Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies"],"prefix":"10.1016","volume":"180","author":[{"given":"Charalampos","family":"Mamoulakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsarouhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Fragkiadoulaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Heretis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Wilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetrios A.","family":"Spandidos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Tsitsimpikou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristides","family":"Tsatsakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2017.06.009_bb0005","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0003319714546527","article-title":"Long-term follow-up of patients at high risk for nephropathy after contrast exposure","volume":"66","author":"Abaci","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jacr.2008.09.014","article-title":"In emergency situations, should serum creatinine be checked in all patients before performing second contrast CT examinations within 24hours?","volume":"6","author":"Abujudeh","year":"2009","journal-title":"Journal of the American College of Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0015","series-title":"ACR manual on contrast media (10.2 ed.)","author":"ACR Committee on Drugs and Contrast Media","year":"2016"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2008.10.006","article-title":"Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions","volume":"139","author":"Aguiar-Souto","year":"2010","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00246-010-9680-2","article-title":"Risk of nephropathy after consumption of nonionic contrast media by children undergoing cardiac angiography: A prospective study","volume":"31","author":"Ajami","year":"2010","journal-title":"Pediatric Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0030","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/JIM.0000000000000243","article-title":"Is kidney injury molecule 1 a valuable tool for the early diagnosis of contrast-induced nephropathy?","volume":"63","author":"Akdeniz","year":"2015","journal-title":"Journal of Investigative Medicine"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1177\/0003319714549556","article-title":"The role of statins in preventing contrast-induced acute kidney injury: A narrative review","volume":"66","author":"Akyuz","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0040","doi-asserted-by":"crossref","first-page":"610","DOI":"10.5603\/KP.a2016.0007","article-title":"Protective effects of anti-oxidant supplementations on contrast-induced nephropathy after coronary angiography: An updated and comprehensive meta-analysis and systematic review","volume":"74","author":"Ali-Hassan-Sayegh","year":"2016","journal-title":"Kardiologia Polska"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1345\/aph.1P275","article-title":"Intravenous N-acetylcysteine in the prevention of contrast media-induced nephropathy","volume":"45","author":"Anderson","year":"2011","journal-title":"The Annals of Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0050","first-page":"362725","article-title":"Acute kidney injury by radiographic contrast media: Pathogenesis and prevention","volume":"2014","author":"Andreucci","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0055","doi-asserted-by":"crossref","first-page":"823169","DOI":"10.1155\/2014\/823169","article-title":"Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors","volume":"2014","author":"Andreucci","year":"2014","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0060","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1259\/bjr\/16327485","article-title":"Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model","volume":"85","author":"Ari","year":"2012","journal-title":"The British Journal of Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0065","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cjca.2015.05.013","article-title":"Contrast-induced nephropathy: From pathophysiology to preventive strategies","volume":"32","author":"Azzalini","year":"2016","journal-title":"The Canadian Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiology.188.1.8511292","article-title":"Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media","volume":"188","author":"Barrett","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMcp050801","article-title":"Clinical practice. Preventing nephropathy induced by contrast medium","volume":"354","author":"Barrett","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2214\/AJR.08.1310","article-title":"Contrast-induced nephropathy: Contrast material not required?","volume":"191","author":"Baumgarten","year":"2008","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.5152\/dir.2015.14075","article-title":"In vivo nephroprotective efficacy of propolis against contrast-induced nephropathy","volume":"21","author":"Baykara","year":"2015","journal-title":"Diagnostic and Interventional Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144329","article-title":"Resin from Virola oleifera protects against radiocontrast-induced nephropathy in mice","volume":"10","author":"Boa","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/0003319714533588","article-title":"Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"66","author":"Borekci","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5414\/CNP68279","article-title":"Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction","volume":"68","author":"Boscheri","year":"2007","journal-title":"Clinical Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1292\/jvms.13-0202","article-title":"The effect of l-carnitine on oxidative stress responses of experimental contrast-induced nephropathy in rats","volume":"76","author":"Boyacioglu","year":"2014","journal-title":"The Journal of Veterinary Medical Science"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ccd.20592","article-title":"Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures","volume":"67","author":"Briguori","year":"2006","journal-title":"Catheterization and Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MNH.0000000000000106","article-title":"Contrast-induced acute kidney injury: Potential new strategies","volume":"24","author":"Briguori","year":"2015","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00204-010-0626-5","article-title":"Nephrotoxicity of contrast media and protective effects of acetylcysteine","volume":"85","author":"Briguori","year":"2011","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0130","doi-asserted-by":"crossref","first-page":"568738","DOI":"10.1155\/2014\/568738","article-title":"Novel biomarkers for contrast-induced acute kidney injury","volume":"2014","author":"Briguori","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0135","doi-asserted-by":"crossref","first-page":"578974","DOI":"10.1155\/2014\/578974","article-title":"Hemodynamic and tubular changes induced by contrast media","volume":"2014","author":"Caiazza","year":"2014","journal-title":"BioMed Research International"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2017.06.009_bb0140","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/ccd.22376","article-title":"Evidence-based management of patients undergoing PCI: Contrast-induced acute kidney injury","volume":"75","author":"Caixeta","year":"2010","journal-title":"Catheterization and Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/08860220802064739","article-title":"Ionic high-osmolar contrast medium causes oxidant stress in kidney tissue: Partial protective role of ascorbic acid","volume":"30","author":"Cetin","year":"2008","journal-title":"Renal Failure"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0150","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1046\/j.1523-1755.2001.00722.x","article-title":"Calpain inhibitor-1 reduces renal ischemia\/reperfusion injury in the rat","volume":"59","author":"Chatterjee","year":"2001","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0155","doi-asserted-by":"crossref","first-page":"F362","DOI":"10.1152\/ajprenal.90609.2008","article-title":"Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats","volume":"297","author":"Choi","year":"2009","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jcrc.2013.03.007","article-title":"Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: Different definitions, different results","volume":"28","author":"Chousterman","year":"2013","journal-title":"Journal of Critical Care"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.etp.2009.02.119","article-title":"Novel approach for the prevention of contrast nephropathy","volume":"62","author":"Colbay","year":"2010","journal-title":"Experimental and Toxicologic Pathology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0170","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2214\/AJR.14.14259","article-title":"Contrast media controversies in 2015: Imaging patients with renal impairment or risk of contrast reaction","volume":"204","author":"Davenport","year":"2015","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0175","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2214\/AJR.13.11369","article-title":"The challenges in assessing contrast-induced nephropathy: Where are we now?","volume":"202","author":"Davenport","year":"2014","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0180","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1148\/radiol.13122276","article-title":"Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: Risk stratification by using estimated glomerular filtration rate","volume":"268","author":"Davenport","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0185","article-title":"Sildenafil prevents renal dysfunction in contrast media-induced nephropathy in Wistar rats","author":"de Almeida","year":"2016","journal-title":"Human & Experimental Toxicology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0190","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1681\/ASN.2015070832","article-title":"Bridging translation by improving preclinical study design in AKI","volume":"26","author":"de Caestecker","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0195","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ndt\/gfh868","article-title":"Lights and shadows on the pathogenesis of contrast-induced nephropathy: State of the art","volume":"20","author":"Detrenis","year":"2005","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5301\/jn.5000067","article-title":"Effect of administration route on the renal safety of contrast agents: A meta-analysis of randomized controlled trials","volume":"25","author":"Dong","year":"2012","journal-title":"Journal of Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0205","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijcard.2011.11.035","article-title":"Feasibility study of the RenalGuard balanced hydration system: A novel strategy for the prevention of contrast-induced nephropathy in high risk patients","volume":"166","author":"Dorval","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.rcl.2009.06.003","article-title":"Prevention of contrast-induced nephropathy: An overview","volume":"47","author":"Ellis","year":"2009","journal-title":"Radiologic Clinics of North America"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0215","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.acra.2004.07.015","article-title":"Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: An experimental study in pigs","volume":"11","author":"Elmstahl","year":"2004","journal-title":"Academic Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ndt\/gfp501","article-title":"Outcome definitions in non-dialysis intervention and prevention trials in acute kidney injury (AKI)","volume":"25","author":"Endre","year":"2010","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0225","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/ndt\/gfh272","article-title":"Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients","volume":"19","author":"Erley","year":"2004","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2215\/CJN.02590607","article-title":"N-acetylcysteine in the prevention of contrast-induced nephropathy","volume":"3","author":"Fishbane","year":"2008","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0235","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.amjmed.2014.05.011","article-title":"Statins and contrast-induced acute kidney injury with coronary angiography","volume":"127","author":"Gandhi","year":"2014","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0240","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1503\/cmaj.1040847","article-title":"Nephropathy induced by contrast media: Pathogenesis, risk factors and preventive strategies","volume":"172","author":"Goldenberg","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0245","first-page":"51","article-title":"Contrast-induced nephropathy; a literature review","volume":"3","author":"Golshahi","year":"2014","journal-title":"Journal of Nephropathology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0250","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0255","doi-asserted-by":"crossref","first-page":"123589","DOI":"10.1155\/2013\/123589","article-title":"Why is diabetes mellitus a risk factor for contrast-induced nephropathy?","volume":"2013","author":"Heyman","year":"2013","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060009","article-title":"Prevention of contrast-induced acute kidney injury: Is simple oral hydration similar to intravenous? A systematic review of the evidence","volume":"8","author":"Hiremath","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0265","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/1440-1681.12487","article-title":"Physicochemical properties of radiographic contrast media, potential nephrotoxicity and prophylaxis","volume":"42","author":"Hogstrom","year":"2015","journal-title":"Clinical and Experimental Pharmacology & Physiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0270","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00228-013-1494-8","article-title":"N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: From preclinical data to clinical evidence","volume":"69","author":"Hosseinjani","year":"2013","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0275","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1128\/AAC.01597-10","article-title":"Sesame oil prevents acute kidney injury induced by the synergistic action of aminoglycoside and iodinated contrast in rats","volume":"55","author":"Hsu","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0280","doi-asserted-by":"crossref","first-page":"F495","DOI":"10.1152\/ajprenal.00642.2012","article-title":"Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury","volume":"305","author":"Ishihara","year":"2013","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0285","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1253\/circj.CJ-12-0096","article-title":"Sodium bicarbonate therapy for the prevention of contrast-induced acute kidney injury \u2014 A systematic review and meta-analysis","volume":"76","author":"Jang","year":"2012","journal-title":"Circulation Journal"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0290","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ejrad.2011.02.003","article-title":"Viscosity of iodinated contrast agents during renal excretion","volume":"80","author":"Jost","year":"2011","journal-title":"European Journal of Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0295","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RLI.0b013e3181d4a036","article-title":"The impact of the viscosity and osmolality of iodine contrast agents on renal elimination","volume":"45","author":"Jost","year":"2010","journal-title":"Investigative Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/clc.20687","article-title":"Contrast-induced kidney injury: Focus on modifiable risk factors and prophylactic strategies","volume":"33","author":"Kagan","year":"2010","journal-title":"Clinical Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0305","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0002-8703(90)90006-J","article-title":"High-dose contrast agent administration during complex coronary angioplasty","volume":"120","author":"Kahn","year":"1990","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2007.09.019","article-title":"Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography","volume":"51","author":"Kane","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0315","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/0886022X.2015.1012985","article-title":"N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: A systematic review and meta-analysis","volume":"37","author":"Kang","year":"2015","journal-title":"Renal Failure"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0320","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jvir.2011.03.020","article-title":"Contrast medium-induced acute kidney injury: Comparison of intravenous and intraarterial administration of iodinated contrast medium","volume":"22","author":"Karlsberg","year":"2011","journal-title":"Journal of Vascular and Interventional Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0325","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/0003319714550309","article-title":"Contrast-induced nephropathy: An \u201call or none\u201d phenomenon?","volume":"66","author":"Katsiki","year":"2015","journal-title":"Angiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1148\/radiol.10092000","article-title":"Intravenous contrast medium-induced nephrotoxicity: Is the medical risk really as great as we have come to believe?","volume":"256","author":"Katzberg","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0335","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ndt\/gfs602","article-title":"Contrast-induced acute kidney injury: How much contrast is safe?","volume":"28","author":"Keaney","year":"2013","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0340","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1007\/s00330-015-3624-4","article-title":"No increase in Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin excretion following intravenous contrast enhanced-CT","volume":"25","author":"Kooiman","year":"2015","journal-title":"European Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0345","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jss.2015.01.041","article-title":"Ozone preconditioning attenuates contrast-induced nephropathy in rats","volume":"195","author":"Kurtoglu","year":"2015","journal-title":"The Journal of Surgical Research"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0350","doi-asserted-by":"crossref","first-page":"20120272","DOI":"10.1259\/bjr.20120272","article-title":"Measures used to treat contrast-induced nephropathy: Overview of reviews","volume":"86","author":"Kwok","year":"2013","journal-title":"The British Journal of Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0355","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jcrc.2011.05.010","article-title":"Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: Incidence and outcome","volume":"26","author":"Lakhal","year":"2011","journal-title":"Journal of Critical Care"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113598","article-title":"Sildenafil citrate for prophylaxis of nephropathy in an animal model of contrast-induced acute kidney injury","volume":"9","author":"Lauver","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0365","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0929-6646(09)60146-7","article-title":"Effects of different contrast media on glutathione peroxidase and superoxide dismutase activities in the heart and kidneys of normal and streptozotocin-induced diabetic rats","volume":"105","author":"Lee","year":"2006","journal-title":"Journal of the Formosan Medical Association"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0370","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/RLI.0b013e318258502b","article-title":"The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety","volume":"47","author":"Lenhard","year":"2012","journal-title":"Investigative Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0375","first-page":"335","article-title":"Statin treatment before percutaneous coronary intervention","volume":"5","author":"Leoncini","year":"2013","journal-title":"Journal of Thoracic Disease"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0380","article-title":"Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: A meta-analysis of seven randomized controlled trials","volume":"7","author":"Li","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0385","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40256-016-0164-5","article-title":"Efficacy of short-term statin treatment for the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography\/percutaneous coronary intervention: A meta-analysis of 21 randomized controlled trials","volume":"16","author":"Li","year":"2016","journal-title":"American Journal of Cardiovascular Drugs"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0390","article-title":"Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0395","doi-asserted-by":"crossref","first-page":"F864","DOI":"10.1152\/ajprenal.00302.2013","article-title":"Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback","volume":"306","author":"Liu","year":"2014","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0400","doi-asserted-by":"crossref","first-page":"308316","DOI":"10.1155\/2014\/308316","article-title":"Prophylaxis of contrast-induced nephrotoxicity","volume":"2014","author":"Ludwig","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0405","doi-asserted-by":"crossref","first-page":"23829","DOI":"10.1074\/jbc.M500800200","article-title":"BH3-only BIK regulates BAX, BAK-dependent release of Ca2+ from endoplasmic reticulum stores and mitochondrial apoptosis during stress-induced cell death","volume":"280","author":"Mathai","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0410","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2214\/ajr.155.2.2115244","article-title":"Preston M. Hickey memorial lecture. Ionic and nonionic iodinated contrast media: Evolution and strategies for use","volume":"155","author":"McClennan","year":"1990","journal-title":"American Journal of Roentgenology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0415","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000332384","article-title":"Effects of intra-arterial and intravenous iso-osmolar contrast medium (iodixanol) on the risk of contrast-induced acute kidney injury: A meta-analysis","volume":"1","author":"McCullough","year":"2011","journal-title":"Cardiorenal Medicine"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0420","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality","volume":"103","author":"McCullough","year":"1997","journal-title":"The American Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0425","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.13130775","article-title":"Risk of intravenous contrast material-mediated acute kidney injury: A propensity score-matched study stratified by baseline-estimated glomerular filtration rate","volume":"271","author":"McDonald","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0430","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.12121460","article-title":"Frequency of acute kidney injury following intravenous contrast medium administration: A systematic review and meta-analysis","volume":"267","author":"McDonald","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0435","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Critical Care"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0440","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0445","first-page":"541","article-title":"Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization","volume":"114","author":"Michael","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0450","first-page":"214","article-title":"Can selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphadiesterase type 5 (PDE 5) offer protection against contrast induced nephropathy?","volume":"4","author":"Morcos","year":"2014","journal-title":"Quantitative Imaging in Medicine and Surgery"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0455","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2008.08.033","article-title":"Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: A systematic review and meta-analysis","volume":"53","author":"Navaneethan","year":"2009","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0460","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00232-012-9512-9","article-title":"Role of contrast media on oxidative stress, Ca(2+) signaling and apoptosis in kidney","volume":"246","author":"Naziroglu","year":"2013","journal-title":"The Journal of Membrane Biology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0465","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1148\/radiol.13122876","article-title":"Quantitating contrast medium-induced nephropathy: Controlling the controls","volume":"267","author":"Newhouse","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0470","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1067\/j.cpradiol.2015.04.002","article-title":"Contrast-induced nephropathy: Identifying the risks, choosing the right agent, and reviewing effective prevention and management methods","volume":"44","author":"Nicola","year":"2015","journal-title":"Current Problems in Diagnostic Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0475","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00330-011-2371-4","article-title":"Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?","volume":"22","author":"Nyman","year":"2012","journal-title":"European Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0480","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.acthis.2009.02.005","article-title":"Sildenafil attenuates renal ischemia reperfusion injury by decreasing leukocyte infiltration","volume":"112","author":"Oruc","year":"2010","journal-title":"Acta Histochemica"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0485","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.carj.2012.11.002","article-title":"Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: Update 2012","volume":"65","author":"Owen","year":"2014","journal-title":"Canadian Association of Radiologists Journal"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0490","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5152\/akd.2014.5380","article-title":"The protective effect of single dose tadalafil in contrast-induced nephropathy: An experimental study","volume":"15","author":"Ozbek","year":"2015","journal-title":"Anatolian Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0495","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/jama.295.23.2765","article-title":"Prophylaxis strategies for contrast-induced nephropathy","volume":"295","author":"Pannu","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0500","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijcard.2011.05.045","article-title":"Effect of statin therapy on contrast-induced nephropathy after coronary angiography: A meta-analysis","volume":"151","author":"Pappy","year":"2011","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0505","doi-asserted-by":"crossref","first-page":"236930","DOI":"10.1155\/2014\/236930","article-title":"Pharmacological strategies to prevent contrast-induced acute kidney injury","volume":"2014","author":"Pattharanitima","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0510","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.amjcard.2014.12.047","article-title":"Prevention of contrast-induced acute kidney injury after percutaneous coronary intervention for chronic total coronary occlusions","volume":"115","author":"Pavlidis","year":"2015","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0515","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1681\/ASN.2006050542","article-title":"Calpain activation and secretion promote glomerular injury in experimental glomerulonephritis: Evidence from calpastatin-transgenic mice","volume":"17","author":"Peltier","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0520","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1523-1755.2005.00377.x","article-title":"Pathophysiology of contrast medium-induced nephropathy","volume":"68","author":"Persson","year":"2005","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0525","doi-asserted-by":"crossref","first-page":"868321","DOI":"10.1155\/2013\/868321","article-title":"Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy","volume":"2013","author":"Pisani","year":"2013","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0530","first-page":"424","article-title":"Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury","volume":"18","author":"Pisani","year":"2014","journal-title":"Clinical and Experimental Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0535","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tiv.2006.09.018","article-title":"Effects of iodinated contrast media on endothelium: An in vitro study","volume":"21","author":"Ramponi","year":"2007","journal-title":"Toxicology In Vitro"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0540","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejvs.2015.12.013","article-title":"Commentary on \u201cContrast induced nephropathy and long-term renal decline after percutaneous transluminal angioplasty for symptomatic peripheral arterial disease\u201d","volume":"51","author":"Rancic","year":"2016","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0545","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneph.2013.282","article-title":"Acute kidney injury-epidemiology, outcomes and economics","volume":"10","author":"Rewa","year":"2014","journal-title":"Nature Reviews. Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0550","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.lfs.2016.02.007","article-title":"Protective effect of erythropoietin on myocardial apoptosis in rats exposed to carbon monoxide","volume":"148","author":"Rezaee","year":"2016","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0555","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","article-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","volume":"105","author":"Rihal","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0560","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehn197","article-title":"Contrast agents and renal cell apoptosis","volume":"29","author":"Romano","year":"2008","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0565","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pharmthera.2013.09.006","article-title":"Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits","volume":"141","author":"Rushworth","year":"2014","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0570","first-page":"62","article-title":"Contrast-induced nephropathy in percutaneous coronary interventions: Pathogenesis, risk factors, outcome, prevention and treatment","volume":"128","author":"Russo","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0575","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2013.07.065","article-title":"Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: A systematic review with meta-analysis of randomized, controlled trials","volume":"62","author":"Sadat","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0580","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bcp.2013.01.006","article-title":"Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases","volume":"85","author":"Saito","year":"2013","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0585","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00380-010-0078-0","article-title":"Intravenous glutathione prevents renal oxidative stress after coronary angiography more effectively than oral N-acetylcysteine","volume":"26","author":"Saitoh","year":"2011","journal-title":"Heart and Vessels"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0590","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11255-014-0820-0","article-title":"Sodium bicarbonate infusion for prevention of acute kidney injury: No evidence for superior benefit, but risk for harm?","volume":"47","author":"Schiffl","year":"2015","journal-title":"International Urology and Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0595","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.vph.2012.10.004","article-title":"Endothelial safety of radiological contrast media: Why being concerned","volume":"58","author":"Scoditti","year":"2013","journal-title":"Vascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0600","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1148\/radiol.10091485","article-title":"Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat","volume":"256","author":"Seeliger","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0605","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1681\/ASN.2006111216","article-title":"Viscosity of contrast media perturbs renal hemodynamics","volume":"18","author":"Seeliger","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0610","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/eurheartj\/ehr494","article-title":"Contrast-induced kidney injury: Mechanisms, risk factors, and prevention","volume":"33","author":"Seeliger","year":"2012","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0615","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ccd.21902","article-title":"Contrast administration in pediatric cardiac catheterization: Dose and adverse events","volume":"73","author":"Senthilnathan","year":"2009","journal-title":"Catheterization and Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0620","doi-asserted-by":"crossref","first-page":"934947","DOI":"10.1155\/2014\/934947","article-title":"Contrast media: Are there differences in nephrotoxicity among contrast media?","volume":"2014","author":"Solomon","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0625","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.0000146396.19081.73","article-title":"Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention","volume":"110","author":"Spargias","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0630","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","article-title":"Contrast induced nephropathy: Updated ESUR Contrast Media Safety Committee guidelines","volume":"21","author":"Stacul","year":"2011","journal-title":"European Radiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0635","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/MNH.0b013e32830f45a3","article-title":"Clinical significance and preventive strategies for contrast-induced nephropathy","volume":"17","author":"Sterling","year":"2008","journal-title":"Current Opinion in Nephrology and Hypertension"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0640","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/M15-1456","article-title":"Effectiveness of prevention strategies for contrast-induced nephropathy: A systematic review and meta-analysis","volume":"164","author":"Subramaniam","year":"2016","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0645","series-title":"AHRQ comparative effectiveness reviews, report no.: 15(16)-EHC023-EF","article-title":"Contrast-induced nephropathy: Comparative effectiveness of preventive measures [internet]","author":"Subramaniam","year":"2016"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0650","doi-asserted-by":"crossref","first-page":"463608","DOI":"10.1155\/2014\/463608","article-title":"Nonpharmacological strategies to prevent contrast-induced acute kidney injury","volume":"2014","author":"Susantitaphong","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0655","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1253\/circj.CJ-10-0622","article-title":"Prediction of chronic renal insufficiency after coronary angiography by an early increase in oxidative stress and decrease in glomerular filtration rate","volume":"75","author":"Tajiri","year":"2011","journal-title":"Circulation Journal"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0660","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijcard.2011.08.047","article-title":"A meta-analysis of randomized trials for effects of periprocedural atorvastatin on contrast-induced nephropathy","volume":"153","author":"Takagi","year":"2011","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0665","first-page":"510385","article-title":"Mechanisms of contrast-induced nephropathy reduction for saline (NaCl) and sodium bicarbonate (NaHCO3)","volume":"2014","author":"Tasanarong","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0670","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1472-6882-14-138","article-title":"Antioxidant effect of Phyllanthus emblica extract prevents contrast-induced acute kidney injury","volume":"14","author":"Tasanarong","year":"2014","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0675","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","article-title":"Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine","volume":"343","author":"Tepel","year":"2000","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0680","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3109\/0886022X.2010.495441","article-title":"Contrast-induced nephropathy after a second contrast exposure","volume":"32","author":"Trivedi","year":"2010","journal-title":"Renal Failure"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0685","doi-asserted-by":"crossref","first-page":"14K","DOI":"10.1016\/j.amjcard.2006.01.020","article-title":"Pathophysiology of contrast-induced nephropathy","volume":"98","author":"Tumlin","year":"2006","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0690","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/028418519303400117","article-title":"Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney","volume":"34","author":"Ueda","year":"1993","journal-title":"Acta Radiologica"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0695","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2014.07.059","article-title":"Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography","volume":"114","author":"Ukaigwe","year":"2014","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0700","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/joic.12204","article-title":"Reduced glutathione for prevention of renal outcomes in patients undergoing selective coronary angiography or intervention","volume":"28","author":"Wang","year":"2015","journal-title":"Journal of Interventional Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0705","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.12659\/MSM.895543","article-title":"Renal protective effect of probucol in rats with contrast-induced nephropathy and its underlying mechanism","volume":"21","author":"Wang","year":"2015","journal-title":"Medical Science Monitor"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0710","doi-asserted-by":"crossref","first-page":"203458","DOI":"10.1155\/2014\/203458","article-title":"Magnolin protects against contrast-induced nephropathy in rats via antioxidation and antiapoptosis","volume":"2014","author":"Wang","year":"2014","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0715","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.2215\/CJN.11161012","article-title":"Prevention of contrast-induced AKI: A review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial","volume":"8","author":"Weisbord","year":"2013","journal-title":"Clinical Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0720","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ccc.2015.06.008","article-title":"Contrast-associated acute kidney injury","volume":"31","author":"Weisbord","year":"2015","journal-title":"Critical Care Clinics"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0725","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00431-017-2907-y","article-title":"Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury","volume":"176","author":"Westhoff","year":"2017","journal-title":"European Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0730","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1136\/hrt.2010.218677","article-title":"Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention","volume":"97","author":"Wi","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0735","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s11255-012-0363-1","article-title":"The effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: A meta-analysis of randomized controlled trials","volume":"45","author":"Wu","year":"2013","journal-title":"International Urology and Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0740","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003968","article-title":"Effectiveness of N-acetylcysteine for the prevention of contrast-induced nephropathy: A systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Xu","year":"2016","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0745","article-title":"Rosuvastatin treatment for preventing contrast-induced acute kidney injury after cardiac catheterization: A meta-analysis of randomized controlled trials","volume":"94","author":"Yang","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0750","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.cjca.2011.05.005","article-title":"High-dose statin pretreatment for the prevention of contrast-induced nephropathy: A meta-analysis","volume":"27","author":"Zhang","year":"2011","journal-title":"The Canadian Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0755","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006989","article-title":"The efficacy of sodium bicarbonate in preventing contrast-induced nephropathy in patients with pre-existing renal insufficiency: A meta-analysis","volume":"5","author":"Zhang","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0760","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000326269","article-title":"Statins for the prevention of contrast-induced nephropathy: A systematic review and meta-analysis","volume":"33","author":"Zhang","year":"2011","journal-title":"American Journal of Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0765","doi-asserted-by":"crossref","first-page":"9825623","DOI":"10.1155\/2016\/9825623","article-title":"Sulforaphane attenuates contrast-induced nephropathy in rats via Nrf2\/HO-1 pathway","volume":"2016","author":"Zhao","year":"2016","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0770","article-title":"Renalase protects against contrast-induced nephropathy in Sprague-Dawley rats","volume":"10","author":"Zhao","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0775","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2169\/internalmedicine.51.6260","article-title":"Prevention of contrast-induced nephropathy with ascorbic acid","volume":"51","author":"Zhou","year":"2012","journal-title":"Internal Medicine"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0780","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5414\/CN106950","article-title":"Short-term, high-dose statins in the prevention of contrast-induced nephropathy: A systematic review and meta-analysis","volume":"76","author":"Zhou","year":"2011","journal-title":"Clinical Nephrology"},{"key":"10.1016\/j.pharmthera.2017.06.009_bb0785","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-151-9-200911030-00008","article-title":"Systematic review: Sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy","volume":"151","author":"Zoungas","year":"2009","journal-title":"Annals of Internal Medicine"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725817301572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725817301572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T02:55:52Z","timestamp":1692845752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725817301572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":157,"alternative-id":["S0163725817301572"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2017.06.009","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2017.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}